valine and Hypertrophy, Left Ventricular

valine has been researched along with Hypertrophy, Left Ventricular in 49 studies

Research

Studies (49)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's7 (14.29)18.2507
2000's28 (57.14)29.6817
2010's14 (28.57)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, G; He, QY; Pan, SF; Pan, SQ; Shen, C; Zhang, XM1
Chang, F; Gui-Yi, Y; Mao-Huan, L; Shu-Xian, Z; Wei, W; Zhi-Bin, H1
Harada, E; Hattori, T; Matsuura, N; Murohara, T; Nagasawa, K; Nagata, K; Niinuma, K; Takahashi, K; Takatsu, M; Watanabe, S1
Xu, C; Xu, J; Zhao, L1
Bai, F; Chang, P; Li, X; Lin, X; Wang, Q; Xu, H; Yang, M; Yu, J; Zhang, X; Zhang, Z; Zhao, F; Zhao, X1
Imaizumi, T; Kai, H; Kuwahara, F; Mizoguchi, M; Mizuta, Y; Nakaura, H; Osada, K; Tahara, N1
Bader, M; Carretero, OA; Rhaleb, NE; Shesely, EG; Xu, J; Yang, JJ; Yang, XP1
Arnold, JM; Bourgoun, M; Califf, RM; Ghali, JK; Kober, L; McMurray, JJ; Meris, A; Pfeffer, MA; Skali, H; Solomon, SD; Velazquez, EJ; Verma, A1
Inoue, M; Iwano, H; Kaga, S; Komatsu, H; Matsuno, K; Mikami, T; Nishida, M; Okada, M; Onozuka, H; Shimizu, C; Tsutsui, H; Yamada, S; Yokoyama, S1
Divchev, D; Grothusen, A; Luchtefeld, M; Schieffer, B1
Bellocci, F; Crea, F; Giubilato, G; Ierardi, C; Pieroni, M; Santangeli, P; Vitulano, N1
Gong, C; Huang, JF; Huang, SL; Jiang, XJ; Luo, M; Zhang, ZF; Zhao, Y1
Kimura, S; Matsubara, H; Sawada, T; Shiraishi, J; Yamada, H1
Bains, J; Smith, WB1
Hasegawa, H; Kobayashi, Y; Komuro, I; Kuwabara, Y; Mizuma, H; Narumi, H; Shindo, S; Takano, H1
Hasebe, N; Ishihara, T; Kawabe, J; Kikuchi, K; Kobayashi, M; Maruyama, H; Nakagawa, N; Ota, H; Sakamoto, N; Sasaki, Y; Seino, U; Takahashi, F; Takenaka, T; Takeuchi, T; Tanabe, Y; Yamauchi, A1
Gurbuz, S; Kucukler, N; Kurt, IH; Topaloglu, C; Yalcin, F1
Ebina, T; Hibi, K; Kimura, K; Kosuge, M; Kusama, I; Morita, S; Nozawa, N; Okuda, J; Ozaki, H; Tsukahara, K; Umemura, S; Yano, H1
Derosa, G; Fogari, R; Maffioli, P; Mugellini, A; Preti, P; Zoppi, A1
Krum, H; Martin, J1
Bedigian, MP; Falk, SA; Gengaro, PE; Gurevich, AK; Nemenoff, RA; Rizeq, M; Schrier, RW; Summer, SN; Weinberger, HD1
deBlois, D; Der Sarkissian, S; Duguay, D; Hamet, P; Marchand, EL1
Kanno, Y; Nakamoto, H; Okada, H; Sugahara, S; Suzuki, H1
Aizawa, Y; Kamimura, T; Kato, K; Soda, S; Suzuki, K1
Asada, A; Maeda, K; Nakamura, M; Watanabe, T; Yasunari, K; Yoshikawa, J1
Fu, H; Li, Y; Lu, Z; Ma, Y; Xiao, J1
Anan, F; Hara, M; Nakagawa, M; Ooie, T; Saikawa, T; Takahashi, N; Yonemochi, H; Yoshimatsu, H; Yufu, K1
Anavekar, NS; Arnold, JM; Barvik, S; Bourgoun, M; Califf, RM; Ghali, JK; Khrakovskaya, M; McMurray, JV; Pfeffer, MA; Schwartz, Y; Skali, H; Solomon, SD; Velazquez, EJ; Warnica, JW1
Laverty, R; Ledingham, JM1
Dahlöf, B1
Birkenhäger, WH; Hansen, TW; Staessen, JA1
Abu-Hijleh, M; Garadah, T; Golbahar, J; Gumaa, K; Kassab, S; Senok, S; Wazir, J1
Fujiwara, H; Hukunishi, M; Ito, Y; Kakami, M; Kawasaki, M; Matsuno, Y; Minatoguchi, S; Miyajima, K; Nishigaki, K; Takemura, G1
Ahmed, A; Husain, A; Perry, GJ1
Arnold, JM; Aurigemma, GP; Bourgoun, M; Daley, WL; Fields, H; Hippler, SE; Janardhanan, R; Lacourcière, Y; Mulvagh, SL; Naqvi, TZ; Purkayastha, D; Solomon, SD; Thomas, JD; Verma, A; Zile, MR1
Julius, S; Mann, J1
Harder, S; Kenedi, P; Rietbrock, N; Schmidt, A; Thürmann, PA1
Thürmann, PA2
Balaev, VV; Drozdova, GA; Frolov, VA; Mustiatsa, VF; Rieger, P1
Balaev, VV; Drozdova, GA; Frolov, VA; Mustiatsa, VF1
Gottdiener, JS1
Devereux, RB1
Ahonen, J; Finckenberg, P; Krogerus, L; Lassila, M; Nurminen, ML; Pere, AK; Vapaatalo, H1
Basset, A; Blanc, J; Elghozi, JL; Hagège, A; Messas, E1
Hannan, RD; Krum, H; Lim, S; See, F; Tzanidis, A; Ugoni, AM1
Cao, H; Ke, YS; Yang, T1
Huang, J; Xiang, Y1
Erbaş, C; Erdine, S; Gültekin, N; Güven, O; Küçükoglu, MS; Mutlu, H; Okçün, B; Okuyan, E; Ozhan, H; Uner, S; Yigit, Z1

Reviews

5 review(s) available for valine and Hypertrophy, Left Ventricular

ArticleYear
Angiotensin II type 1 receptor blockade: high hopes sent back to reality?
    Minerva cardioangiologica, 2009, Volume: 57, Issue:6

    Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Cardiovascular Diseases; Consensus; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Follow-Up Studies; Heart Failure; Hospitalization; Humans; Hypertension; Hypertrophy, Left Ventricular; Middle Aged; Practice Guidelines as Topic; Primary Prevention; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Risk Factors; Saralasin; Secondary Prevention; Stroke; Tetrazoles; Time Factors; Treatment Outcome; Valine; Valsartan

2009
Valsartan plus hydrochlorothiazide: a review of its use since its introduction.
    Expert opinion on pharmacotherapy, 2011, Volume: 12, Issue:12

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Diuretics; Drug Combinations; Drug Costs; Drug Synergism; Humans; Hydrochlorothiazide; Hypertension; Hypertrophy, Left Ventricular; Renal Insufficiency; Tetrazoles; Valine; Valsartan; Ventricular Dysfunction, Left

2011
Role of valsartan and other angiotensin receptor blocking agents in the management of cardiovascular disease.
    Pharmacological research, 2002, Volume: 46, Issue:3

    Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Cardiac Output, Low; Cardiovascular Diseases; Clinical Trials as Topic; Diabetes Mellitus; Humans; Hypertension; Hypertrophy, Left Ventricular; Kidney Failure, Chronic; Myocardial Infarction; Renin-Angiotensin System; Tetrazoles; Valine; Valsartan

2002
Valsartan and the renin-angiotensin-aldosterone system: blood pressure control and beyond.
    Journal of the renin-angiotensin-aldosterone system : JRAAS, 2000, Volume: 1, Issue:2 Suppl

    Topics: Angiotensin II Type 1 Receptor Blockers; Blood Pressure; Blood Vessels; Humans; Hypertrophy, Left Ventricular; Kidney Diseases; Renin-Angiotensin System; Tetrazoles; Valine; Valsartan

2000
Therapeutic options in minimizing left ventricular hypertrophy.
    American heart journal, 2000, Volume: 139, Issue:1 Pt 2

    Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Cardiovascular Diseases; Humans; Hypertension; Hypertrophy, Left Ventricular; Receptors, Angiotensin; Renin-Angiotensin System; Tetrazoles; Valine; Valsartan

2000

Trials

19 trial(s) available for valine and Hypertrophy, Left Ventricular

ArticleYear
Long-term treatment with valsartan improved cyclic variation of the myocardial integral backscatter signal and diastolic dysfunction in hypertensive patients: the echocardiographic assessment.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2008, Volume: 31, Issue:10

    Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Echocardiography; Female; Fibrosis; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Myocardium; Prospective Studies; Tetrazoles; Treatment Outcome; Valine; Valsartan; Ventricular Dysfunction, Left

2008
Prognostic implications of left ventricular mass and geometry following myocardial infarction: the VALIANT (VALsartan In Acute myocardial iNfarcTion) Echocardiographic Study.
    JACC. Cardiovascular imaging, 2008, Volume: 1, Issue:5

    Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Cardiovascular Diseases; Europe; Female; Heart Ventricles; Humans; Hypertrophy, Left Ventricular; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Predictive Value of Tests; Proportional Hazards Models; Recurrence; Risk Assessment; Risk Factors; Tetrazoles; Time Factors; Treatment Outcome; Ultrasonography; United States; Valine; Valsartan; Ventricular Remodeling

2008
Effects of combined therapy of Xuezhikang Capsule and Valsartan on hypertensive left ventricular hypertrophy and heart rate turbulence.
    Chinese journal of integrative medicine, 2010, Volume: 16, Issue:2

    Topics: Administration, Oral; Aged; Antihypertensive Agents; Arrhythmias, Cardiac; Capsules; Combined Modality Therapy; Drug Combinations; Drugs, Chinese Herbal; Female; Heart Rate; Humans; Hypertension; Hypertrophy, Left Ventricular; Hypolipidemic Agents; Integrative Medicine; Male; Medicine, Chinese Traditional; Middle Aged; Tetrazoles; Treatment Outcome; Valine; Valsartan

2010
Enhanced cardiovascular protective effects of valsartan in high-risk hypertensive patients with left ventricular hypertrophy--sub-analysis of the KYOTO HEART study.
    Circulation journal : official journal of the Japanese Circulation Society, 2011, Volume: 75, Issue:4

    Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Electrocardiography; Female; Follow-Up Studies; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Risk Factors; Tetrazoles; Valine; Valsartan

2011
Effects of valsartan and amlodipine on home blood pressure and cardiovascular events in Japanese hypertensive patients: a subanalysis of the VART.
    Journal of human hypertension, 2012, Volume: 26, Issue:11

    Topics: Aged; Albuminuria; Amlodipine; Angina Pectoris; Antihypertensive Agents; Asian People; Blood Pressure; Cardiovascular Diseases; Cause of Death; Creatinine; Death, Sudden; Female; Heart Failure; Humans; Hypertension; Hypertrophy, Left Ventricular; Kidney Failure, Chronic; Male; Middle Aged; Myocardial Infarction; Stroke; Tetrazoles; Treatment Outcome; Valine; Valsartan

2012
Effects of valsartan, an angiotensin II receptor blocker, on coronary atherosclerosis in patients with acute myocardial infarction who receive an angiotensin-converting enzyme inhibitor.
    Circulation journal : official journal of the Japanese Circulation Society, 2012, Volume: 76, Issue:6

    Topics: Aged; Aldosterone; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Biomarkers; Blood Pressure; Captopril; Chi-Square Distribution; Coronary Artery Disease; Drug Therapy, Combination; Female; Humans; Hypertrophy, Left Ventricular; Japan; Logistic Models; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Odds Ratio; Predictive Value of Tests; Prospective Studies; Renin-Angiotensin System; Risk Assessment; Risk Factors; Tetrazoles; Time Factors; Treatment Outcome; Ultrasonography, Interventional; Valine; Valsartan

2012
Effects of valsartan or ramipril addition to amlodipine/hydrochlorothiazide combination on left ventricular mass in diabetic hypertensive patients with left ventricular hypertrophy.
    Expert opinion on pharmacotherapy, 2012, Volume: 13, Issue:8

    Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Ramipril; Tetrazoles; Valine; Valsartan

2012
A selective angiotensin receptor antagonist, Valsartan, produced regression of left ventricular hypertrophy associated with a reduction of arterial stiffness.
    Advances in peritoneal dialysis. Conference on Peritoneal Dialysis, 2003, Volume: 19

    Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Arteries; Blood Flow Velocity; Blood Pressure; Compliance; Creatinine; Double-Blind Method; Echocardiography; Elasticity; Humans; Hypertrophy, Left Ventricular; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Tetrazoles; Valine; Valsartan

2003
Comparative effects of valsartan versus amlodipine on left ventricular mass and reactive oxygen species formation by monocytes in hypertensive patients with left ventricular hypertrophy.
    Journal of the American College of Cardiology, 2004, Jun-02, Volume: 43, Issue:11

    Topics: Amlodipine; Antihypertensive Agents; Cross-Sectional Studies; Double-Blind Method; Echocardiography; Female; Flow Cytometry; Heart Ventricles; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Monocytes; Prospective Studies; Reactive Oxygen Species; Tetrazoles; Treatment Outcome; Valine; Valsartan

2004
Effects of valsartan and perindopril combination therapy on left ventricular hypertrophy and aortic arterial stiffness in patients with essential hypertension.
    European journal of clinical pharmacology, 2005, Volume: 61, Issue:5-6

    Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Ankle; Aorta; Blood Pressure Monitoring, Ambulatory; Drug Therapy, Combination; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Japan; Male; Middle Aged; Natriuretic Peptide, Brain; Perindopril; Prospective Studies; Pulse; Tetrazoles; Valine; Valsartan

2005
Changes in ventricular size and function in patients treated with valsartan, captopril, or both after myocardial infarction.
    Circulation, 2005, Jun-28, Volume: 111, Issue:25

    Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Drug Therapy, Combination; Electrocardiography; Female; Heart Ventricles; Hospitalization; Humans; Hypertrophy, Left Ventricular; Male; Middle Aged; Myocardial Infarction; Prognosis; Stroke Volume; Tetrazoles; Treatment Outcome; Valine; Valsartan; Ventricular Dysfunction, Left

2005
Reduction of QTc dispersion by the angiotensin II receptor blocker valsartan may be related to its anti-oxidative stress effect in patients with essential hypertension.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2007, Volume: 30, Issue:4

    Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Pressure; Collagen Type I; Collagen Type III; Electrocardiography; Female; Follow-Up Studies; Heart Rate; Humans; Hypertension; Hypertrophy, Left Ventricular; Lipid Peroxidation; Long QT Syndrome; Male; Oxidative Stress; Prospective Studies; Tetrazoles; Valine; Valsartan

2007
Effect of angiotensin receptor blockade and antihypertensive drugs on diastolic function in patients with hypertension and diastolic dysfunction: a randomised trial.
    Lancet (London, England), 2007, Jun-23, Volume: 369, Issue:9579

    Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Pressure; Double-Blind Method; Echocardiography; Female; Heart Rate; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Renin-Angiotensin System; Stroke Volume; Tetrazoles; Valine; Valsartan

2007
The Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial of cardiovascular events in hypertension. Rationale and design.
    Blood pressure, 1998, Volume: 7, Issue:3

    Topics: Aged; Amlodipine; Angiotensin II; Antihypertensive Agents; Calcium Channel Blockers; Cardiovascular Diseases; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Prospective Studies; Research Design; Risk Factors; Tetrazoles; Treatment Outcome; Valine; Valsartan

1998
Influence of the angiotensin II antagonist valsartan on left ventricular hypertrophy in patients with essential hypertension.
    Circulation, 1998, Nov-10, Volume: 98, Issue:19

    Topics: Angiotensin II; Antihypertensive Agents; Atenolol; Blood Pressure; Double-Blind Method; Echocardiography; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Tetrazoles; Treatment Outcome; Valine; Valsartan

1998
Angiotensin II antagonism and the heart: valsartan in left ventricular hypertrophy.
    Journal of cardiovascular pharmacology, 1999, Volume: 33 Suppl 1

    Topics: Angiotensin II; Antihypertensive Agents; Atenolol; Blood Pressure; Double-Blind Method; Female; Humans; Hydrochlorothiazide; Hypertrophy, Left Ventricular; Male; Middle Aged; Tetrazoles; Valine; Valsartan

1999
Angiotensin II antagonism and the heart: valsartan in left ventricular hypertrophy.
    Cardiology, 1999, Volume: 91 Suppl 1

    Topics: Aged; Antihypertensive Agents; Atenolol; Calcium Channel Blockers; Double-Blind Method; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Tetrazoles; Treatment Outcome; Valine; Valsartan

1999
Influence of the angiotensin II antagonist valsartan on left ventricular hypertrophy in patients with essential hypertension.
    Circulation, 1999, Aug-10, Volume: 100, Issue:6

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensive Agents; Atenolol; Diuretics; Drug Interactions; Heart Ventricles; Humans; Hydrochlorothiazide; Hypertension; Hypertrophy, Left Ventricular; Organ Size; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Research Design; Tetrazoles; Valine; Valsartan

1999
The efficacy of valsartan in essential hypertension and its effects on left ventricular hypertrophy.
    Blood pressure, 2002, Volume: 11, Issue:1

    Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Cohort Studies; Hemodynamics; Humans; Hypertension; Hypertrophy, Left Ventricular; Middle Aged; Tetrazoles; Therapeutic Equivalency; Treatment Outcome; Ultrasonography; Valine; Valsartan

2002

Other Studies

25 other study(ies) available for valine and Hypertrophy, Left Ventricular

ArticleYear
Puerarin inhibits angiotensin II-induced cardiac hypertrophy via the redox-sensitive ERK1/2, p38 and NF-κB pathways.
    Acta pharmacologica Sinica, 2014, Volume: 35, Issue:4

    Topics: Administration, Oral; Angiotensin II; Animals; Antioxidants; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Gene Expression Regulation; Hypertrophy, Left Ventricular; Isoflavones; Male; Mice, Inbred C57BL; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Myocytes, Cardiac; NF-kappa B; Oxidation-Reduction; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Reactive Oxygen Species; Signal Transduction; Tetrazoles; Ultrasonography; Valine; Valsartan; Ventricular Remodeling

2014
Valsartan improves the electrophysiological characteristics of left ventricular hypertrophic myocardium in spontaneously hypertensive rats.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2014, Volume: 37, Issue:9

    Topics: Animals; Blood Pressure; Heart Ventricles; Hypertrophy, Left Ventricular; Male; Myocardium; Rats; Rats, Inbred SHR; Shal Potassium Channels; Tetrazoles; Valine; Valsartan

2014
Comparative effects of valsartan in combination with cilnidipine or amlodipine on cardiac remodeling and diastolic dysfunction in Dahl salt-sensitive rats.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2015, Volume: 38, Issue:1

    Topics: Amlodipine; Animals; Antihypertensive Agents; Dihydropyridines; Drug Evaluation, Preclinical; Drug Therapy, Combination; Heart; Hypertension; Hypertrophy, Left Ventricular; Male; Myocytes, Cardiac; Oxidative Stress; Rats, Inbred Dahl; Renin-Angiotensin System; Tetrazoles; Valine; Valsartan; Ventricular Remodeling

2015
Autoantibodies against β1 receptor and AT1 receptor in type 2 diabetes patients with left ventricular dilatation.
    Cardiology, 2014, Volume: 129, Issue:3

    Topics: Aged; Antihypertensive Agents; Autoantibodies; Biomarkers; Diabetes Mellitus, Type 2; Dilatation, Pathologic; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Metoprolol; Middle Aged; Predictive Value of Tests; Receptor, Angiotensin, Type 1; Receptors, Adrenergic, beta-1; Risk Factors; Sensitivity and Specificity; Tetrazoles; Valine; Valsartan

2014
Tetrahydrobiopterin reverse left ventricular hypertrophy and diastolic dysfunction through the PI3K/p-Akt pathway in spontaneously hypertensive rats.
    Biochemical and biophysical research communications, 2015, Aug-07, Volume: 463, Issue:4

    Topics: Animals; Biopterins; Blood Pressure; Body Weight; Diastole; Hypertension; Hypertrophy, Left Ventricular; Male; Organ Size; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Tetrazoles; Valine; Valsartan

2015
The kinin B1 receptor contributes to the cardioprotective effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in mice.
    Experimental physiology, 2009, Volume: 94, Issue:3

    Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Collagen; Disease Models, Animal; Female; Heart Rate; Hypertrophy, Left Ventricular; Ligation; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardial Infarction; Myocytes, Cardiac; Ramipril; Receptor, Bradykinin B1; Tetrazoles; Valine; Valsartan; Ventricular Dysfunction, Left

2009
Angiotensin II receptor blocker, valsartan, increases myocardial blood volume and regresses hypertrophy in hypertensive patients.
    Circulation journal : official journal of the Japanese Circulation Society, 2009, Volume: 73, Issue:11

    Topics: Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Blood Pressure; Blood Volume; Case-Control Studies; Echocardiography, Doppler; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Tetrazoles; Valine; Valsartan

2009
Continuous positive airway pressure treatment in addition to optimal medical therapy for ventricular ectopy in a patient with heart failure and sleep-related breathing disorder.
    Journal of cardiovascular medicine (Hagerstown, Md.), 2013, Volume: 14, Issue:9

    Topics: Adrenergic beta-Antagonists; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Carbazoles; Carvedilol; Continuous Positive Airway Pressure; Coronary Artery Disease; Heart Failure; Humans; Hypertrophy, Left Ventricular; Male; Middle Aged; Propanolamines; Radiography; Sleep Apnea, Obstructive; Tachycardia, Ventricular; Tetrazoles; Ultrasonography; Valine; Valsartan; Ventricular Premature Complexes

2013
Clinical and genetic investigation of a Japanese family with cardiac fabry disease. Identification of a novel α-galactosidase A missense mutation (G195V).
    International heart journal, 2011, Volume: 52, Issue:5

    Topics: Adult; alpha-Galactosidase; Amino Acid Substitution; Bundle-Branch Block; Coronary Angiography; Coronary Vasospasm; DNA Mutational Analysis; Echocardiography; Electrocardiography; Exons; Fabry Disease; Female; Genotype; Glycine; Humans; Hypertrophy, Left Ventricular; Japan; Magnetic Resonance Imaging; Male; Microscopy, Electron; Middle Aged; Mutation, Missense; Myocardium; Natriuretic Peptide, Brain; Pedigree; Peptide Fragments; Signal Processing, Computer-Assisted; Valine; Young Adult

2011
The effect of valsartan on left ventricular myocardial functions in hypertensive patients with left ventricular hypertrophy.
    Journal of cardiovascular medicine (Hagerstown, Md.), 2012, Volume: 13, Issue:3

    Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Biomechanical Phenomena; Blood Pressure; Echocardiography, Doppler; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Myocardial Contraction; Prospective Studies; Recovery of Function; Tetrazoles; Time Factors; Treatment Outcome; Turkey; Valine; Valsartan; Ventricular Function, Left

2012
Effects of angiotensin receptor blockade on haemodynamics and gene expression after myocardial infarction.
    Drugs in R&D, 2002, Volume: 3, Issue:4

    Topics: Angiotensin Receptor Antagonists; Animals; Gene Expression Regulation; Hemodynamics; Hypertrophy, Left Ventricular; Male; Myocardial Infarction; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Tetrazoles; Valine; Valsartan

2002
Reversal of interstitial fibroblast hyperplasia via apoptosis in hypertensive rat heart with valsartan or enalapril.
    Cardiovascular research, 2003, Volume: 57, Issue:3

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Apoptosis; Enalapril; Fibroblasts; Heart Ventricles; Hyperplasia; Hypertension; Hypertrophy, Left Ventricular; In Situ Nick-End Labeling; Male; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Tetrazoles; Valine; Valsartan

2003
The effect of valsartan on regression of left ventricular hypertrophy in type 2 diabetic patients.
    Diabetes, obesity & metabolism, 2004, Volume: 6, Issue:3

    Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Pressure; Body Mass Index; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Drug Administration Schedule; Echocardiography; Female; Glycated Hemoglobin; Heart Ventricles; Humans; Hypertrophy, Left Ventricular; Male; Middle Aged; Tetrazoles; Valine; Valsartan

2004
Effects of volsartan on transmural heterogeneous changes of transient outward potassium currents in hypertrophic cardiomyocytes in rabbits.
    Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban, 2004, Volume: 24, Issue:5

    Topics: Animals; Antihypertensive Agents; Biological Transport, Active; Female; Hypertrophy, Left Ventricular; Male; Myocytes, Cardiac; Patch-Clamp Techniques; Potassium Channels; Rabbits; Tetrazoles; Valine; Valsartan

2004
Effects of glitazones on blood pressure and vascular structure in mesenteric resistance arteries and basilar artery from genetically hypertensive rats.
    Clinical and experimental pharmacology & physiology, 2005, Volume: 32, Issue:11

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Basilar Artery; Blood Pressure; Disease Models, Animal; Drug Therapy, Combination; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Hypertrophy, Left Ventricular; Mesenteric Arteries; Pioglitazone; Rats; Rats, Inbred SHR; Rats, Wistar; Rosiglitazone; Simvastatin; Tetrazoles; Thiazolidinediones; Tunica Media; Valine; Valsartan

2005
Added VALUE of an ancillary study on ambulatory blood pressure monitoring.
    Journal of hypertension, 2007, Volume: 25, Issue:3

    Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Heart Rate; Humans; Hypertrophy, Left Ventricular; Randomized Controlled Trials as Topic; Reproducibility of Results; Research; Sample Size; Tetrazoles; Valine; Valsartan

2007
The angiotensin type 1 receptor antagonist valsartan attenuates pathological ventricular hypertrophy induced by hyperhomocysteinemia in rats.
    Journal of the renin-angiotensin-aldosterone system : JRAAS, 2006, Volume: 7, Issue:4

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Blood Pressure; Homocysteine; Hyperhomocysteinemia; Hypertrophy, Left Ventricular; Male; Organ Size; Rats; Rats, Inbred F344; Receptor, Angiotensin, Type 1; Tetrazoles; Valine; Valsartan; Ventricular Remodeling

2006
VALIDD should not invalidate angiotensin-receptor blockers.
    Lancet (London, England), 2007, Jun-23, Volume: 369, Issue:9579

    Topics: Angiotensin II Type 1 Receptor Blockers; Blood Pressure; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Myocardial Infarction; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Tetrazoles; Valine; Valsartan

2007
[Myocardial hypertrophy in rabbits with vasorenal arterial hypertension during pharmacological blockade of formation of angiotensin II and its interaction with specific receptors].
    Biulleten' eksperimental'noi biologii i meditsiny, 1999, Volume: 127, Issue:5

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Cardiomegaly; Hypertension, Renovascular; Hypertrophy, Left Ventricular; Male; Myocardium; Rabbits; Receptors, Angiotensin; Tetrazoles; Valine; Valsartan

1999
[Morphofunctional characteristics of myocardial hypertrophy in rabbits with vasorenal arterial hypertension during pharmacological blockade of angiotensin II].
    Doklady Akademii nauk, 1999, Volume: 366, Issue:3

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Heart Ventricles; Hypertension, Renovascular; Hypertrophy, Left Ventricular; Male; Organ Size; Rabbits; Tetrazoles; Valine; Valsartan

1999
Comparison of enalapril and valsartan in cyclosporine A-induced hypertension and nephrotoxicity in spontaneously hypertensive rats on high-sodium diet.
    British journal of pharmacology, 2000, Volume: 130, Issue:6

    Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Body Weight; Bradykinin; Bradykinin Receptor Antagonists; Cyclosporine; Dose-Response Relationship, Drug; Drinking; Eating; Electrolytes; Enalapril; Heart Rate; Hypertension; Hypertrophy, Left Ventricular; Kallikreins; Kidney; Kidney Diseases; Male; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptor, Bradykinin B2; Renin; Sodium, Dietary; Tetrazoles; Urination; Valine; Valsartan

2000
Renin-angiotensin system contribution to cardiac hypertrophy in experimental hyperthyroidism: an echocardiographic study.
    Journal of cardiovascular pharmacology, 2001, Volume: 37, Issue:2

    Topics: Animals; Echocardiography; Hyperthyroidism; Hypertrophy, Left Ventricular; Male; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Renin-Angiotensin System; Tetrazoles; Valine; Valsartan

2001
Combined angiotensin and endothelin receptor blockade attenuates adverse cardiac remodeling post-myocardial infarction in the rat: possible role of transforming growth factor beta(1).
    Journal of molecular and cellular cardiology, 2001, Volume: 33, Issue:5

    Topics: Angiotensin Receptor Antagonists; Animals; Blotting, Northern; Bosentan; Collagen; Endothelin Receptor Antagonists; Female; Fibroblasts; Hemodynamics; Hypertrophy, Left Ventricular; Immunohistochemistry; Macrophages; Monocytes; Myocardial Infarction; Myocardium; Procollagen; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sulfonamides; Tetrazoles; Time Factors; Transforming Growth Factor beta; Transforming Growth Factor beta1; Valine; Valsartan; Ventricular Dysfunction, Left

2001
Effect of combination of valsartan with benazepril on blood pressure and left ventricular hypertrophy in SHR.
    Acta pharmacologica Sinica, 2000, Volume: 21, Issue:11

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzazepines; Blood Pressure; Drug Therapy, Combination; Hypertension; Hypertrophy, Left Ventricular; Male; Random Allocation; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Tetrazoles; Valine; Valsartan

2000
Effect of valsartan and fosinopril on catecholamine-induced cardiac hypertrophy.
    Acta pharmacologica Sinica, 2000, Volume: 21, Issue:9

    Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Apoptosis; Calcium-Transporting ATPases; Collagen; Female; Fosinopril; Hypertrophy, Left Ventricular; Male; Myocardium; Norepinephrine; Rats; Rats, Sprague-Dawley; Sodium-Potassium-Exchanging ATPase; Tetrazoles; Valine; Valsartan; Ventricular Remodeling

2000